Palisade Bio, Inc. (PALI)
NASDAQ: PALI · IEX Real-Time Price · USD
4.760
-0.150 (-3.05%)
At close: May 28, 2024, 4:00 PM
5.00
+0.24 (5.04%)
After-hours: May 28, 2024, 5:14 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $4.46 million as of May 28, 2024. Its market cap has decreased by -57.55% in one year.
Market Cap
4.46M
Enterprise Value
-6.66M
1-Year Change
-57.55%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $4.46M, a decrease of -94.59%. That is a compound annual growth rate of -15.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 24, 2024 | 4.60M | -4.17% |
May 23, 2024 | 4.80M | - |
May 22, 2024 | 4.80M | -5.88% |
May 21, 2024 | 5.10M | -7.27% |
May 20, 2024 | 5.50M | -8.33% |
May 17, 2024 | 6.00M | -1.64% |
May 16, 2024 | 6.10M | 1.67% |
May 15, 2024 | 6.00M | 1.69% |
May 14, 2024 | 5.90M | 1.72% |
May 13, 2024 | 5.80M | 1.75% |
May 10, 2024 | 5.70M | -3.39% |
May 9, 2024 | 5.90M | -1.67% |
May 8, 2024 | 6.00M | -10.45% |
May 7, 2024 | 6.70M | -6.94% |
May 6, 2024 | 7.20M | 9.09% |
May 3, 2024 | 6.60M | 6.45% |
May 2, 2024 | 6.20M | 3.33% |
May 1, 2024 | 6.00M | 17.65% |
Apr 30, 2024 | 5.10M | -3.77% |
Apr 29, 2024 | 5.30M | 1.92% |
Apr 26, 2024 | 5.20M | -1.89% |
Apr 25, 2024 | 5.30M | -1.85% |
Apr 24, 2024 | 5.40M | 8.00% |
Apr 23, 2024 | 5.00M | 19.05% |
Apr 22, 2024 | 4.20M | 5.00% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Regional Health Properties | 4.78M |
China Pharma Holdings | 4.68M |
Artelo Biosciences | 4.65M |
Genprex | 4.62M |
MyMD Pharmaceuticals | 4.62M |
Nuwellis | 4.50M |
ReShape Lifesciences | 4.41M |
GeoVax Labs | 4.40M |